Home LiteratureArticle Details

PMID: 17040255 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.

Journal of internal medicine ·Vol. 260 ·No. 5 ·2006-11-00 ·Pages 484-7

Inui T, Asakawa A, Morita Y, Mizuno S, Natori T, Kawaguchi A, Murakami M, Hishikawa Y, Inui A

Abstract

暂无摘要

MeSH Terms

Adenocarcinoma/drug therapy,metabolism,secondary Aged, 80 and over Antibodies, Monoclonal/therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents/therapeutic use Fatal Outcome Gene Amplification/genetics Genes, erbB-2 Humans Japan Liver Neoplasms/drug therapy,metabolism,secondary Male Neoplasm Proteins/metabolism Receptor, ErbB-2/metabolism Stomach Neoplasms/drug therapy,metabolism,pathology Trastuzumab

Chemicals

Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Agents Neoplasm Proteins Receptor, ErbB-2 Trastuzumab

Authors & Affiliations

9 authors, click to expand affiliations / ORCID

Inui T

Inui Clinic, Kagoshima, Japan.

Asakawa A

Morita Y

Mizuno S

Natori T

Kawaguchi A

Murakami M

Hishikawa Y

Inui A

Article Info

Journal

Journal of internal medicine

Abbr.

J Intern Med

ISSN

0954-6820

DOI

10.1111/j.1365-2796.2006.01715.x

Published

2006-11-00

Pages

484-7

Language

English

Region

England

NLM ID

8904841

Subset

External Links

PubMed source DOI: 10.1111/j.1365-2796.2006.01715.x View journal details

Analysis Services

HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.

Contact

WeChat Official Account